Core Laboratories N.V. (CLB) NYSE
13.60
-0.27(-1.95%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
13.60
-0.27(-1.95%)
Currency In USD
| Market Cap | 745.4M |
| Enterprise Value | 928.88M |
| P/E Ratio | 21.58 |
| PEG Ratio | 2.59 |
| Price/Sales Ratio | 1.19 |
| Price/Book Ratio | 2.28 |
| Enterprise/Revenue | 1.23 |
| Enterprise/EBITDA | 8.92 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.06 |
| Operating Margin | 0.1 |
| Return On Assets | 0.05 |
| Return On Equity | 0.11 |
| Revenue | 526.52M |
| Revenue/Share | 11.39 |
| Gross Profit | 94.28M |
| EBITDA | 71.12M |
| Net Income | 29.67M |
| Diluted EPS | 0.68 |
| Total Cash | 22.82M |
| Total Cash/Share | 0.5 |
| Total Debt | 41.29M |
| Total Debt/Equity | 0.15 |
| Current Ratio | 2.05 |
| Book Value Per Share | 5.97 |
| 52-Week Change | 27.7 |
| 52-Week High | 20.36 |
| 52-Week Low | 9.72 |
| Moving Average 50 Days | 15.36 |
| Moving Average 200 Days | 15.38 |
| Average Volume | 452,255 |
| Shares Outstanding | 46.1M |
| % Held by Institutions | 108.67 |
| Trailing Annual Dividend Rate | 0.04 |
| Trailing Annual Dividend Yield | 0.29 |
| Payout Ratio | 0.07 |
| Last Split Factor | 2:1 |
| Last Split Date | July 09, 2010 |